Intract Pharma Alternatives & Competitors
12 companies similar to Intract Pharma — Transforming Patient Care by Replacing Injections with Safer, More Effective The...
Companies similar to Intract Pharma
Alchemab Therapeutics Ltd
Pioneering Patient-led Antibody Therapeutics
London, United Kingdom
Avacta Therapeutics
Expanding the reach of highly potent cancer therapies with the pre|CISION® platform.
London, United Kingdom
Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesi...
Emeryville, United States
Cellarity
Rewriting the rules of drug creation
Somerville, United States
Rival Readout
Competing with Intract Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Dewpoint Therapeutics
Translating condensate biology into medicine.
Boston, United States
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Seattle, United States
Avalyn Pharma
Revolutionizing respiratory care with every breath
Boston, United States
Vial
Vial is a next-gen pharma company advancing best-in-class biologics and RNA therapeutics a...
San Francisco, United Sta...
Pentixapharm AG
improves the life of patients with malignant diseases through targeted molecular diagnosti...
Berlin, Germany
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Sunnyvale, United States
Arecor Therapeutics
Improving health and life for people living with diabetes, obesity and other cardiometabol...
Cambridge, United Kingdom
About Intract Pharma
Intract Pharma is a dynamic biotechnology company committed to advancing patient care by transforming traditional injectable therapies into oral formulations. Founded in 2016 and headquartered in the United Kingdom, the company is pioneering innovations in the oral delivery of complex proteins, particularly focusing on...
Development of oral drug delivery systems, Biotech drug formulations, Collaborative biopharmaceutical research and development, Preclinical research and trials
Pharmaceutical companies, Healthcare providers, Patients requiring biologic therapies, Biotech organizations
Oral Drug Delivery, Biotechnology Innovation, Monoclonal Antibodies, Gastrointestinal Treatment, Immune-mediated Inflammatory Diseases, Phloral™ Technology, Soteria™ Technology, Protein Delivery, Systemic Immunomodulation, Colon Targeted Delivery, Injectable To Oral Conversion, Biologic Medicines, Proprietary Formulation Technologies, University Spin-out, Pharmaceutical Research And Development
B2B, Platform, B2B2C
Licensing, Project Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Intract Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Intract Pharma on 2 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
